Thursday, August 13, 2015 2:02:54 PM
Recent AWH News
- Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/28/2024 11:30:00 AM
- Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference • GlobeNewswire Inc. • 03/21/2024 12:00:00 PM
- Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024 • GlobeNewswire Inc. • 03/11/2024 12:00:00 PM
- Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference • GlobeNewswire Inc. • 02/22/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:54:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 01:17:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 01:11:43 AM
- Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI) • GlobeNewswire Inc. • 02/12/2024 01:00:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/07/2024 09:21:10 PM
- Aspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the Philippines • GlobeNewswire Inc. • 02/06/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 01:31:35 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/26/2024 10:25:56 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/26/2024 10:19:59 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/26/2024 10:12:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 10:31:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:39:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:41:58 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/26/2023 10:17:07 PM
- Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024 • GlobeNewswire Inc. • 12/19/2023 01:00:00 PM
- Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024 • GlobeNewswire Inc. • 12/14/2023 01:00:00 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM